Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivermectin Will be Used as an Outpatient Treatment Option for COVID-19 Patients.

NCT05045937 is registered in ClinicalTrials.gov with Patrick Robinson as lead sponsor.

NCT NCT05045937
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05045937 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivermectin Will be Used as an Outpatient Treatment Option for COVID-19 Patients.
Lead sponsor
Patrick Robinson
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2022
Completion date
May 1, 2024
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19 acute bronchitis, covid-19 pneumonia, covid-19 respiratory infection, covid19